Aveo Pharmaceuticals Inc AVEO:NASDAQ

Last Price$3.95NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/14/22

Today's Change+0.15(3.95%)
Bid (Size)$3.85 (2)
Ask (Size)$3.99 (2)
Day Low / High$3.76 - 3.98
Volume214.1 K

Aveo Pharmaceuticals' Head, Neck Cancer Drug Gets FDA Fast-Track Designation

9:23AM ET 9/20/2021 MT Newswires
Aveo Pharmaceuticals (AVEO) said Monday the US Food and Drug Administration granted ficlatuzumab, its investigational drug being developed for the potential treatment of head and neck cancer, a fast-track designation.

The designation was granted based on positive results from the company's phase 2 study, which evaluated ficlatuzumab as a standalone therapy or in combination with cetuximab. Patients who received the combination therapy showed a superior overall response rate and median progression-free survival.

A fast-track designation is given to speed the review of drugs to treat serious conditions and fulfill an unmet medical need.

Price: 6.81, Change: -0.08, Percent Change: